Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
4
Mins
30th March 2014
Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14
Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14
3
Mins
27th March 2014
Yogurt in Nutrition Initiative Welcomes the Expertise of the International Osteoporosis Foundation as It Highlights the Role of Dairy Products on Bone Health
The importance of dairy products, including yogurt, to bone health has been recognised again today with the announcement of a new collaboration between…
2
Mins
27th March 2014
Norgine and Innovacell Dose First Patient in Phase IIb Clinical Trial of ICEF15, a Personalised Cell Therapy to Treat Faecal Incontinence
Norgine B.V. (“Norgine”) and Innovacell today announced that the first patient has been dosed in the Phase IIb STEFFI study, which has been designed to…
1
Mins
14th March 2014
‘Early Access’ Scheme Unveiled for Innovative Medicines
People with advanced cancer and other serious illnesses like dementia could soon benefit from early access to innovative and promising treatments.
4
Mins
21st February 2014
NICE Consults on Draft Guidance Recommending New Drug for Type 2 Diabetes
NICE, the health and social care guidance body, is currently appraising canagliflozin (Invokana, Janssen-Cilag) when used in combination with…
21st February 2014
Novel Anticoagulants in Atrial Fibrillation
This educational seminar, supported by an independent educational grant from Daiichi Sankyo, was held at the AHA congress in Dallas on 19th November 2013.
21st February 2014
Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation – (Engage Af – Timi 48 Trial): Primary Results
The following is an executive summary of the abstract presentation by Prof Robert Giugliano on the ENGAGE AF – TIMI 48 trial primary results.
1
Mins
20th February 2014
Cancer Scan Avoids Exposing Younger Patients to Radiation
A new method of scanning young cancer patients for tumours has been developed that avoids exposing them to potentially harmful radiation…
2
Mins
19th February 2014
The Musical Brain: Novel Study of Jazz Players Shows Common Brain Circuitry Processes Both Music and Language
The brains of jazz musicians engrossed in spontaneous, improvisational musical conversation showed robust activation of brain areas traditionally…
3
Mins
14th February 2014
Luxembourg National Health Fund Approves Reimbursement of XIFAXAN® 550
London, 14 February 2014. 13:00 GMT: Norgine today announced that Luxembourg’s National Health Fund, the Caisse Nationale de Santé (CNS), has approved…
←
1
2
3
…
866
867
868
869
870
871
872
…
880
881
882
→